<DOC>
	<DOCNO>NCT01496963</DOCNO>
	<brief_summary>This multicenter observational case-control analysis last 12 month aim determine prevalence pulmonary hypertension ( PAH ) patient Thalassemia Major Intermedia . The patient follow , treat examined accord best standard clinical practice dictate Italian Society study Hemoglobinopathies ( SITE ) , Thalassemia International Federation ( TIF ) Task Force Diagnosis Treatment Pulmonary Hypertension European Society Cardiology ( ESC ) ; European Respiratory Society ( ERS ) ; International Society Heart Lung Transplantation ( ISHLT ) guideline .</brief_summary>
	<brief_title>Prevalence Pulmonary Hypertension ( PAH ) Patients With Thalassemia</brief_title>
	<detailed_description>The recent International Classification pulmonary arterial hypertension ( PHA ) include Hemoglobinopathies Class I . At present determination prevalence disease large population thalassemic patient follow uniform way . The diagnostic criterion use normal population may suitable population thalassemia patient present feature like chronic anemia , iron overload , liver disease , endocrine disorder , etc . The criterion use define disease ( PHA ) one dictate mention guideline . Primary Objective study determination prevalence severity PHA thalassemia syndrome , recently introduce Class I Classification PHA . Secondary objective : Critical evaluation current diagnostic criterion derive applied general population , take account peculiarity observe disease thalassemic population . Evaluation sensitivity specificity echocardiogram versus right cardiac catheterization ( RHC ) . Evaluation correlation : echocardiography RHC ; resistance heart rate determine RHC echocardiography ; Determination patient result vasoreactive RHC . Validation sensitivity specificity ( sens/spec ) 6 minute walk test ( 6MWT ) brain natriuretic peptide ( BNP ) Thalassemia Major ( TM ) Intermediate ( TI ) reference specific pulmonary hypertensive disease In order achieve objective study observed patient divide group accord follow criterion : group ) - Pulmonary artery pressure ( PAP ) assess ( echocardiogram ) &lt; 36 mmHg tricuspid regurgitant jet velocity ( TG ) &lt; 3 m/sec data PAP mean leave ventricular ejection fraction ( LVEF ) &gt; 50 % group b ) - PAP estimate ( echocardiography ) &gt; 40 mmHg TG &gt; 3.2 / sec LVEF &gt; 50 % - As indicated Guidelines , patient b ) increase PAP ( TG &gt; 3.2 / sec &gt; 40 mm Hg ) study use RHC vasoreactivity test . Angio CAT , 6MWT BNP . group c ) - PAP estimate ( echocardiography ) range value &gt; 3 m/sec ( TG ) &lt; 3.2 / sec &gt; 36 mm Hg &lt; 40 mmHg LVEF &gt; 50 % Each case include group b ) c ) pair two control include group ) make group comparable . The group ) serve control group compare diagnostic method evaluate per protocol . In order divide patient three group specify first evaluate : PAP , LVEF % TG assess echocardiographic examination perform six month prior begin study ( thalassemic patient perform echocardiography year monitor cardiac function accord guideline ) Patients belong group ) , b ) c ) perform follow assessment : - Clinical cardiac evaluation accord New York Heart Association ( NYHA ) ( functional class I IV ) As per International Guidelines , patient belong group b ) c ) clinical indication undergo Two-dimensional echocardiography-Doppler Duplex Scanner ( PW ) color flow ( CW ) determine follow parameter : - End-systolic volume leave ventricular end diastolic , indexed accord body surface - Percentage change right ventricular area ( area diastolic/systolic area express percentage % ) - Tricuspid lateral annulus excursion Longitudinal ( TAPS ) - Eccentricity Index ( EI ) - TG - Pulmonary resistance . Moreover , patient belong group b ) , accord International Guidelines clinical indication undergo RHC , diagnostic evaluation rule presence associate disease measure : - Pulmonary pressure - Mean atrial pressure - Pulmonary resistance - Cardiac rate - Vasoreactivity test To compare data derive RHC echocardiography follow echocardiographic parameter evaluate : Right atrial pressure ; Cardiac output ; Pulmonary wedge pressure</detailed_description>
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Hypertension , Pulmonary</mesh_term>
	<mesh_term>Familial Primary Pulmonary Hypertension</mesh_term>
	<mesh_term>Thalassemia</mesh_term>
	<mesh_term>beta-Thalassemia</mesh_term>
	<criteria>Patients Thalassemia Major Patients Intermediate refer Centres use WebThal medical record ( clinical data sheet use congenital anemia . Info : www.thalassemia.it ) Patients consider potentially unreliable and/or cooperative</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>August 2015</verification_date>
	<keyword>Thalassemia</keyword>
	<keyword>Pulmonary Arterial Hypertension</keyword>
</DOC>